Virtu Financial’s Ascendis Pharma A/S ASND Stock Holding History

Virtu Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,002	Closed	-$252K	–	1390
2023 Q4	$252K	Sell	2,002 -993	-33%	-$99K	0.02%	689
2023 Q3	$280K	Buy	+2,995	New	+$280K	0.03%	533
2022 Q2	–	Sell	-1,771	Closed	-$208K	–	1567
2022 Q1	$208K	Sell	1,771 -1,787	-50%	-$207K	0.02%	760
2021 Q4	$479K	Buy	+3,558	New	+$529K	0.05%	391
2021 Q3	–	Sell	-1,682	Closed	-$221K	–	1483
2021 Q2	$221K	Buy	+1,682	New	+$224K	0.02%	927
2020 Q4	–	Sell	-1,787	Closed	-$276K	–	1426
2020 Q3	$276K	Buy	+1,787	New	+$257K	0.05%	469
2019 Q3	–	Sell	-5,483	Closed	-$631K	–	1414
2019 Q2	$631K	Buy	5,483 +3,519	+179%	+$421K	0.04%	447
2019 Q1	$231K	Buy	+1,964	New	+$172K	0.01%	925
2018 Q2	–	Sell	-3,478	Closed	-$227K	–	1966
2018 Q1	$227K	Buy	+3,478	New	+$195K	0.01%	1263

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtu Financial's ASND Position: Q1 2024 in Review

Virtu Financial sold out of Ascendis Pharma A/S (ASND) in Q1 2024, closing a stake of 2,002 shares — an estimated $252K sold.

Virtu Financial first reported a position in ASND in Q1 2018 and held it in 9 quarters. The position peaked at $631K in Q2 2019. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

Virtu Financial reported no remaining Ascendis Pharma A/S position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 2,002 Ascendis Pharma A/S shares in Q1 2024, an estimated $252K.
Virtu Financial first reported a position in Ascendis Pharma A/S in Q1 2018 and held it in 9 quarters.
Virtu Financial's Ascendis Pharma A/S position peaked at $631K in Q2 2019.
189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.